From: Portal vein embolization with absolute ethanol to induce hypertrophy of the future liver remnant
Age (y), median (range) | 62.5 (9–80) |
Gender, n (%) | |
Male | 47 (75.8) |
Female | 15 (24.2) |
Indication of Liver Resection, n (%) | |
Hepatocellular Carcinoma | 23 (37.1) |
Colorectal Metastases | 20 (32.3) |
Cholangiocarcinoma | 13 (21.0) |
Other | 6 (9.7) |
Parenchymal Liver Disease, n (%) | |
Fibrosis | 21 (33.9) |
Steatosis | 8 (12.9) |
Cholestasis | 12 (19.4) |
None | 21 (33.9) |
Pre-Interventional Bilirubin, median (µmol/L) | 10 (3-310) |
Pre-Interventional Albumin, median (g/L) | 38 (23–47) |
Pre-Interventional INR, median | 1.0 (0.9–1.3) |
Diabetes Mellitus, n (%) | 44 (71.0) |